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Leukemia inhibitory factor (LIF), a cytokine at the interface between neurobiology and immunology, is mainly mediated through
JAK/STAT pathway and MAPK/ERK pathway. Evidence suggested LIF is related to the higher expression of neurokinin-1 receptor
(NK-1R)inasthma.Inthisstudy,theimmunohistochemistrystainshowedtheexpressionsofNK-1R,LIF,p-STAT3,andp-ERK1/2
in the lung tissues of allergic rats were increased compared with the controls, and the main positive cell type was airway epithelial
cell.NormalhumanbronchialepithelialcellsweretreatedwithLIFinthepresenceorabsenceofAG490(JAK2inhibitor),PD98059
(MEK inhibitor), and the siRNA against STAT3. Western blot and RT-PCR indicated that LIF induced the expression of NK-1R,
which was inhibited by the inhibitors mentioned above. No signiﬁcant interaction was found between JAK/STAT pathway and
MAPK/ERK pathway. In summary, bronchial epithelial cell changes in asthma are induced by LIF which promotes the expression
of NK-1R, and JAK/STAT pathway and MAPK/ERK pathway may participate in this process.
Copyright © 2006 Cheng-Ping Hu et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Leukemia inhibitory factor (LIF) is a pleiotrophic glycopro-
tein that belongs to the interleukin-6 (IL-6) cytokine family,
which shares gp130 as the signal transducer. In the down-
streamofgp130,twoimportantsignal-transducingpathways
have been recognized, the janus kinase/signal transducer and
activator of transcription (JAK/STAT) pathway and the ras
mitogen-activated protein kinase (MAPK) pathway [1–6].
There is widespread distribution of LIF within human lung
tissue, where its physiological level is very low, but when ex-
posed to proinﬂammatory cytokines such as IL-1β,L I Fg e n e
expression upregulated [7]. In addition, high levels of LIF
were also found in atopic patients and patients with diﬀuse
pulmonary inﬂammation [8, 9].
Similar to the other neurotrophic factors such as nerve
growth factor (NGF), it has been reported that LIF has been
implicated in various processes of neuronal development,
diﬀerentiation, survival and neurogenesis [10–12]. Further-
more, it was indicated that LIF could increase the expression
of substance P and its receptor (neurokinin-1 receptor; NK-
1R) both in mRNA and protein levels [13, 14]. Substance
P and its receptor are main eﬀective substances in airway
neurogenic inﬂammation, Hu et al demonstrated that NGF
upregulates NK-1R expression in normal rat lungs, and the
expression of NK-1R increased in rat lungs which were in-
fected with respiratory syncytial virus [15–17]. These data
suggested that LIF has neuromodulatory role in the airways
and may be an important signal molecule in the airway re-
sponse to inﬂammation [18].
Bronchial epithelial cell is a barrier to airway structure,
and it is an important target cell type in most respiratory
diseases such as asthma. High levels of LIF and NK-1R were
observed in bronchial epithelial cells of asthmatic rats [19].
However, whether the increased expression of NK-1R is re-
lated to LIF is unknown. If so, whether the role of LIF is me-
diated through JAK/STAT pathway and (or) MAPK pathway
needs further investigation.
MATERIALS AND METHODS
Animalpreparationofasthmaticmodels
Healthy male Sprague-Dawley rats, 6 to 8 weeks of age,
were provided by the experimental animal center of Cen-
tral South University. The animals were divided into 2
groups at random (asthmatic group and control group,
n = 10), and they were housed under speciﬁc pathogen-
free conditions. Sensitization (the asthmatic group) was pro-
duced with an intraperitoneal injection of 100mg of chicken
OVA(Sigma), 200mg of aluminum hydroxide(Sigma), and
5 × 109 heat-killed Bordetella pertussis (Wuhan Institute of2 Mediators of Inﬂammation
Biological Products) in 1ml of sterile saline. The sham sen-
sitization group (the control group) was treated by ster-
ile saline intraperitoneal injection. Two weeks later, the rats
in the asthmatic group were placed in a Plexiglas chamber
(20L) and challenged every day with 1% OVA for 30min
using an ultrasonic nebulizer, while those in the control
g r o u pr e c e i v e dﬁ l t e r e da i ro n l y .A f t e rac h a l l e n g ep e r o i d( 1 0
days), the rats were killed by decapitation and bloodletting,
a n dn o n p e r f u s e de x c i s e dl u n gt i s s u e sw e r eﬁ x e di n4 %p o l y -
oxymethylene, then embedded in paraﬃn, and ﬁnally sliced
into sections (5μm thick) for further study. The study proto-
col was in accordance with the guidelines for animal research
and was approved by the Ethical and Research Committee of
the hospital.
Cellculture
Normal human bronchial epithelial (NHBE) cells were ob-
tained from the cell culture collection center of Yuantai
Biosource (it was conducted in accordance with the decla-
ration of Helsinki and the guidelines of the Ethical and Re-
search Committee of the hospital). NHBE cells were cul-
tured in Dulbecco’s modiﬁed Eagle’s medium supplemented
with 10% fetal bovine serum, and cells were maintained
at 37◦ in a humidiﬁed atmosphere containing 5% CO2.
After 24h in serum-free medium, cells were stimulated
with recombinant human LIF(Chemicon) (5ng/ml, 30min
for detecting STAT3 and ERK1/2; 5ng/ml, 24h for detect-
ing NK-1R) in pre-exposure or absence of AG-490 (JAK2
inhibitor, Biosource) (50nmol/mL, 1h), PD-98059 (MEK
inhibitor, Cell signaling technology) (20nmol/mL, 1h),
PMA(ALEXIS Biochemicals) (10ng/mL, 4h), and the small
interfering RNA(siRNA) against STAT3(Genesil Biotechnol-
ogy) (2μg/mL, 24h).
Immunohistochemistryandimmunocytochemistry
Immunoreactivity for phospho-STAT3(p-STAT3), phospho-
ERK1/2(p-ERK1/2), NK-1R and LIF proteins were detected
by streptavidin-biotin peroxidase complex method(SABC)
(Boster Biotechnology). The primary antibodies against rat
p-STAT3(rabbit polyclonal antibody, Santa Cruz Biotech-
nology), p-ERK1/2(mouse polyclonal antibody, Santa
Cruz Biotechnology), NK-1R(rabbit polyclonal antibody,
Novus Biologicals), and LIF(rabbit polyclonal antibody,
Boster Biotechnology) were applied respectively. The sec-
ondary antibodies were aﬃnity-puriﬁed biotinylated goat
anti-rabbit(mouse) IgG (Boster Biotechnology). Nuclei were
counterstained lightly with hematoxylin.
N H B Ec e l l sw e r ep l a t e da ta na p p r o x i m a t ed e n s i t yo f
2×105 cells/cm2 onto tissue culture chamber slides (Lab Tek,
Tokyo)inmediumcontaining10%FBS.After24h,cellswere
replenishedwithserum-freemediumandincubatedfor24h.
NHBE cells were preincubated with or without AG-490, PD-
98059, PMA, or the siRNA against STAT3 and then stimu-
latedwithLIF.Followingthis,thecellswereﬁxedin4%poly-
oxymethylene, and stained with primary antibody against
NK-1R. Primary antibody was detected by aﬃnity-puriﬁed
biotinylatedsecondaryantibody(BosterBiotechnology),and
the stained cells were observed by microscopy. Ten ﬁelds
(×200)werechosenatrandomundermicroscope,andapos-
itive cell ratio was obtained by counting (positive cells num-
ber/total cells number).
RNAinterference
The siRNA oligonucleotide sequences against STAT3
(NM 139276.2) were in accordance with Lee et al and
Konnikova et al [20, 21], siRNA-1: 5 -GATCCGCATC-
TGCCTAGATCGGCTATTCAAGACGTAGCCGATCT-
AGGCAGATGTTTTTTGAATTCA-3 ,3  -GCGTAGA-
CGGATCTAGCCGATAAGTTCTGCATCGGCTAGA-
TCCGTCTACAAAAAACTTAAGTTCGA-5 ; siRNA-2:
5 -GATCCGTGTTCTCTATCAGCACAATTTCAAGAC-
GATTGTGCTGATAGAGAACATTTTTTGAATTCA-3 ,
3 -GCACAAGAGATAGTCGTGTTAAAGTTCTGCTA-
ACACGACTATCTCTTGTAAAAAACTTAAGTTCGA-5;
negative control siRNA: 5 -GATCCGACTTCATAAGGCG-
CATGCTTCAAGACGGCATGCGCCTTATGAAGTCTTT-
TTTGTCGACA-3 ,3  -GCTGAAGTATTCCGCGTACGA-
AGTTCTGCCGTACGCGGAATACTTCAGAAAAAACA-
GCTGTTCGA-5  (synthesized by Genesil Biotechnology).
The siRNAs (2μg/mL) were introduced into cells using
the METAFECTENE highly eﬃcient transfection reagent
(Biontex) according to the manufacturer’s instructions.
Westernblot
Cells were harvested in lysis buﬀer, and the lysates were
cleared by centrifugation at 12000g for 10min at 4◦.T h e
proteins were separated by 10% SDS-PAGE, and transferred
to polyvinylidene diﬂuoride membranes, then probed with
primary antibodies against human STAT3, p-STAT3(tyr)
(rabbit polyclonal antibody, Santa Cruz Biotechnology),
ERK1/2, p-ERK1/2 (mouse polyclonal antibody, Santa Cruz
Biotechnology), GAPDH (rabbit polyclonal antibody, Santa
Cruz Biotechnology). The primary antibodies that bounded
to the target proteins were detected using horseradish
peroxidase-conjugated anti-rabbit IgG(Promega), or anti-
mouse IgG(Cortex Biochem), as appropriate. The antibodies
were visualized with enhanced chemiluminescent detection
(Pierce Biotechnology). The intensity of target bands was
corrected by GAPDH calculated with the FluorChem 8900
software system.
RT-PCR
Total RNAs were extracted using TRIZOL(Invitrogen). cD-
NAs were synthesized using the RevertAid H Minus First
Strand cDNA Synthesis Kit (Fermentas) with oligo(dT)18
primers. The primer sequences used were as follows. Hu-
man NK-1R: forward primer 5  GGGACTCCTCTGACCGC-
TAC 3 , reverse primer 5  TCCAGGCGGCTGACTTTGTA
3 ,PCRproduct376bp(753–1128);humanβ-actin:forward
primer 5  CCTTCCTGGGCATGGAGTC 3 , reverse primer
5  GAGGAGCAATGATCTTGATCTTC 3 ,P C Rp r o d u c tCheng-Ping Hu et al 3
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 1: Expression of NK-1R, LIF, p-STAT3, and p-ERK1/2 in lung tissues of asthmatic rats (SABC × 200). Immunohistochemistry was
performed on lung tissue of asthmatic rats. There were higher expressions for NK-1R ((a) control group, (b) asthmatic group) and LIF ((c)
control group, (d) asthmatic group) in the asthmatic rats than those in the control rats, and the similar changes were observed for p-STAT3
((e) control group, (f) asthmatic group) and p-ERK1/2 ((g) control group, (h) asthmatic group). The main positive cell type was airway
epithelial cell.
204bp (867–1070). RT-PCR analysis was performed as de-
scribed by Hu et al with minor modiﬁcations [15]. The in-
tensity of target mRNA levels was corrected by β-actin tran-
scripts calculated with the FluorChem 8900 software system.
Statisticalanalysis
The data presented in (Figures 1, 2, 3, 4,a n d5)w e r ee x -
pressedasmeans ±SD(n = 3).Statisticalsigniﬁcanceamong
meanvalueswasevaluatedwithanANOVA.Diﬀerenceswere
considered signiﬁcant when P<. 05.
RESULTS
ExpressionofLIF,NK-1R,p-STAT3,andp-ERK1/2in
lungtissuesofasthmaticrats
Immunohistochemistry was performed in lung tissues of
rats, and it indicated a higher expression of LIF in the asth-
matic rats compared to that in the control group. Consis-
tent with that, similar changes were observed for NK-1R, p-
STAT3, and p-ERK1/2. The main positive cell type was air-
way epithelial cell, and other positive types were also ob-
served such as lymphocyte (Figure 1).
EffectsofAG-490,PD-98059,orPMAonLIF-induced
activationofsignaltransductionandactivationof
transcription(STAT3)andERK1/2
Western blot was performed on cells that had been prein-
cubated with or without AG-490, PD-98059, or PMA and
then stimulated with LIF. LIF induced activation of tyrosine
phosphorylation of STAT3 (versus the control cells, P<. 01),
andtyrosinephosphorylationofSTAT3wasinhibitedbyAG-
490 (the cells stimulated with LIF in the presence of AG-
490 versus the cells stimulated with LIF, P<. 01), but not
by PD-98059 (the cells stimulated with LIF in the presence
of PD-98059 versus the cells stimulated with LIF, P>. 05),
and the results also indicated phosphorylation of STAT3 that
was not aﬀected by PMA (Figure 2(a)). Nevertheless, the ex-
pression of total-STAT3 was not aﬀected by the factors men-
tioned above (Figure 2(b)). LIF induced activation of phos-
phorylation of ERK1/2 (versus the control cells, P<. 01),
and ERK1/2 activation was inhibited by PD-98059 (the cells
stimulated with LIF in the presence of PD-98059 versus the
cells stimulated with LIF, P<. 01), but not by AG-490 (the
cells stimulated with LIF in the presence of AG-490 versus
the cells stimulated with LIF, P>. 05) (Figure 2(c)). Sim-
ilar to that of total-STAT3, the expression of total-ERK1/2
did not change (Figures 2(d), 2(e)). PMA increased the ex-
pression of p-ERK1/2 in NHBE cells (versus the control cells,
P<. 01), but there was no signiﬁcant diﬀerence between the
c e l l ss t i m u l a t e dw i t hL I Fa n dt h ec e l l ss t i m u l a t e dw i t hL I Fi n
the presence of PMA.
EffectsofAG-490,PD-98059,orPMAonLIF-induced
expressionofNK-1R
ImmunocytochemistryandRT-PCRwereperformedoncells
that had been preincubated with or without AG-490, PD-
98059, or PMA and then stimulated with LIF. LIF induced
expression of NK-1R in NHBE cells (versus the control cells,
P<. 01), both AG-490 and PD-98059 suppressed the LIF-
induced expression of NK-1R by 58% (the cells stimulated
with LIF in the presence of AG-490 versus the cells stimu-
lated with LIF, P<. 01) and 60% (the cells stimulated with4 Mediators of Inﬂammation
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Figure 2: Eﬀects of AG-490, PD-98059, or PMA on LIF-induced activation of signal transduction and activation of transcription (STAT3) and
ERK1/2. Western blot was performed on NHBE cells that had been preincubated with or without AG-490, PD-98059, or PMA and then
stimulated with LIF. (a) LIF induced activation of tyrosine phosphorylation of STAT3, and tyrosine phosphorylation of STAT3 was inhibited
byAG-490,butnotbyPD-98059,andnotaﬀectedbyPMA.(b)LIFdidnotenhancetheexpressionoftotal-STAT3,anditsexpressionwasnot
aﬀected by AG-490, PD-98059, and PMA. (c) LIF induced activation of phosphorylation of ERK1/2, and ERK1/2 activation was inhibited by
PD-98059, but not by AG-490; PMA increased the expression of p-ERK1/2 in NHBE cells, but there were no signiﬁcant diﬀerences between
the cells stimulated with LIF and the cells stimulated with LIF in the presence of PMA. (d) and (e) LIF did not enhance the expression of
total-ERK1/2, furthermore, AG-490, PD-98059, and PMA also did not aﬀect it. Experiments were repeated three times with similar results,
and the data was expressed as the mean ratio (target/GAPDH) ± SD.
LIF in the presence of PD-98059 versus the cells stimulated
with LIF, P<. 01); on the contrary, PMA increased the ex-
pression of NK-1R in NHBE cells (Figures 3 and 4(a)).
EffectsofsiRNA(STAT3)onLIF-inducedactivationof
signaltransductionandactivationoftranscription
(STAT3)andERK1/2
Western blot was performed on cells that had been preincu-
bated with or without siRNA(STAT3) and then stimulated
with LIF. LIF-induced tyrosine phosphorylation of STAT3
was inhibited by siRNA-1 and siRNA-2, and the inhibition
ratio was 85% and 42%, respectively (Figure 5(a)). In ad-
dition, the expression of total-STAT3 was also inhibited by
siRNA-1 and siRNA-2 (56% and 37%, resp) (Figure 5(b)).
Becauseofthehigherinhibitionratio,siRNA-1waslatercho-
sen for interference in the cells. However, siRNA-1 did not
aﬀect the expression of p-ERK1/2 and total-ERK1/2 (Figures
5(c), 5(d)).
EffectsofsiRNA(STAT3)onLIF-induced
expressionofNK-1R
ImmunocytochemistryandRT-PCRwereperformedon cells
that had been preincubated with or without siRNA-1
(STAT3) and then stimulated with LIF. The LIF-induced ex-
pression of NK-1R was inhibited by siRNA-1 both at the
mRNA level and the protein level (the cells stimulated with
LIF in the presence of siRNA-1 versus the cells stimulated
with LIF, P<. 01), but it was not aﬀected by negative con-
trol siRNA and sham plasmid (the cells stimulated with LIF
in the presence of control siRNA or sham plasmid versus the
c e l l ss t i m u l a t e dw i t hL I F ,P>. 05) (Figures 3 and 4(b)).
DISCUSSION
LIF is a cytokine at the interface between neurobiology and
immunology [22]. Exposure of neural tissue to proinﬂam-
matory cytokines, such as IL-1β or injury, increases theCheng-Ping Hu et al 5
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Figure 3: Eﬀects of AG-490, PD-98059, PMA, or siRNA-1(STAT3) on LIF-induced expression of NK-1R detected by immunocytochem-
istry (SABC × 200). Immunocytochemistry was performed on cells that had been preincubated with or without AG-490, PD-98059, PMA,
or siRNA-1(STAT3) and then stimulated with LIF ((a) control, (b) PD-98059, (c) AG-490, (d) LIF, (e) PMA, (f) LIF + PD-95059, (g) LIF
+ PMA, (h) LIF + AG-490, (i) LIF + control siRNA, (j) LIF + sham plasmid, (k) LIF + siRNA-1 against STAT3). LIF induced expression of
NK-1R, which was inhibited by AG-490, PD-98059, and siRNA-1 against STAT3, but was aﬀected neither by the control siRNA nor the sham
plasmid.Experimentswererepeatedthreetimeswithsimilarresults,andthedatawasexpressedasthemeanratio(positivecellsnumber/total
cells number) ± SD.
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Figure 4: Eﬀects of AG-490, PD-98059, PMA, or siRNA-1(STAT3) on LIF-induced expression of NK-1R detected by RT-PCR.R T - P C Rw a s
performed on cells that had been preincubated with or without AG-490, PD-98059, PMA, or siRNA-1(STAT3) and then stimulated with LIF.
(a) LIF induced expression of NK-1R mRNA, and that was inhibited by AG-490 and PD-98059; PMA increased the expression of NK-1R
mRNA in NHBE cells. (b) LIF-induced expression of NK-1R mRNA was inhibited by siRNA-1 against STAT3, but was aﬀected neither by
the control siRNA nor the sham plasmid. Experiments were repeated three times with similar results, and the data was expressed as the mean
ratio (target/β-actin) ± SD.
synthesis and release of LIF, which in turn increases mRNA
and protein of substance P and its receptor (NK-1R). Simi-
larly, LIF also can induce neuropeptide synthesis and release
in neurons that do not normally produce neuropeptides, and
these studies suggested that LIF has an important neuro-
immune linkage function [13, 14, 23]. LIF dose dependently
augmented eosinophil migration and other functions in re-
sponse to substance P, resulting in bidirectional interactions
between inﬂammatory cells and nerves in allergic diseases
[8].
It was found that serum LIF levels were higher in atopic
patients with mild asthma than in nonatopic normal donors
[8].Consistentwiththat,highlevelsofLIFwerealsofoundin
bronchoalveolar lavage ﬂuid obtained from patients with the
acute respiratory distress syndrome, in which there was dif-
fuse pulmonary inﬂammation [9]. Immunohistochemistry6 Mediators of Inﬂammation
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Figure 5: Eﬀects of siRNA(STAT3) on LIF-induced activation of signal transduction and activation of transcription (STAT3) and ERK1/2.
Western blot was performed on NHBE cells that had been preincubated with or without siRNA(STAT3) and then stimulated with LIF.
(a) LIF induced activation of tyrosine phosphorylation of STAT3, and tyrosine phosphorylation of STAT3 was inhibited by siRNA-1 and
siRNA-2, but neither by control siRNA nor sham plasmid. (b) Similiar to phosphorylation of STAT3, total-STAT3 was inhibited by siRNA-
1 and siRNA-2, but neither by control siRNA nor sham plasmid. (c) LIF induced activation of phosphorylation of ERK1/2, but ERK1/2
activation was not inhibited by siRNA-1 against STAT3. (d) Similiar to phosphorylation of ERK1/2, the expression of total-ERK1/2 was not
aﬀected by siRNA-1 against STAT3. Experiments were repeated three times with similar results, and the data was expressed as the mean
ratio(target/GAPDH) ± SD.
demonstrated the presence of LIF in epithelial cells, mes-
enchymal cells, and nerve ﬁbers in the human airway, and it
was found that these airway structural cell types release LIF
and its receptor (LIFR) in response to inﬂammatory stimuli
such as proinﬂammatory cytokines. Subsequently, LIF aug-
mented contractile responses to tachykinins in airway ex-
plants [7, 24].
In animal models, it was indicated that NK-1R was in-
volved in the development of allergen-induced airway hyper-
reactivity to histamine after both the early asthmatic reac-
tions and late asthmatic reactions, and NK-1R-mediated in-
ﬂammation of airways may contribute to this process [25].
In the present study, the airway tissues of asthmatic rats were
tested by immunohistochemistry, and it was found that LIF
expression in the asthmatic rats was higher than that in the
normal control group, at the same time, NK-1R expression
in the asthmatic rats also increased.
Incubation of rat sympathetic cervical ganglia with LIF
downregulated the expression of muscarinic M2Rm R N A ,
while at the same time increased the expression of substance
P and NK-1R [13, 14]. After incubation of tracheal explants
with LIF, there were no observable increases of substance P
expression compared to the control, however, measurement
of NK-1R expression was not done [18]. Substance P is a
member of tachykinin family, which is usually not steadily
expressed, and is not easily detected. As a ligand, substance
P can express biological eﬀect on the condition of combin-
ing with its speciﬁc receptor NK-1R, and thus, the biological
activity of substance P w o u l db er e ﬂ e c t e db yd e t e c t i n gt h e
expression of NK-1R.
LIF is a pleiotrophic glycoprotein that belongs to the IL-
6 cytokine family, which shares the common gp130 receptor
chain as the signal transducing protein. LIF signaling is me-
diated through the LIF receptor which heterodimerizes with
the gp130 receptor upon LIF binding [5]. Activation of the
LIFR-β-gp130 heterodimer results in the rapid activation of
janus kinases (JAKs) which in turn phosphorylate tyrosine
residuesofLIFR-β andgp130[3,4,6].Thesephosphorylated
tyrosine residues form docking sites for signaling molecules
including STAT3 and SHP2 [4]. STATs are transcription fac-
tors, which form dimers upon phosphorylation of a speciﬁc
tyrosine residue that is located in a conserved SHP2 domain
[26].STATdimerizationallowsnucleartranslocationandthe
transcriptional activation of target genes [26]. SHP2 is a ty-
rosine phosphatase which signals upstream of the Ras/MAP
kinase signal transduction pathway [4, 27–29]. As a result,
downstream of the pathway molecules such as ERK1/2 and
p38 is activated sequentially.Cheng-Ping Hu et al 7
As the important pathways in eukaryocyte, Ras/MEK/
ERK cascade pathway and JAK/STAT cascade pathway may
be closely interrelated. In many cell types in culture, susta-
ined expression of activated Ras or its downstream eﬀector
can elicit cell cycle arrest and diﬀerentiation, and some re-
seachers revealed that the biological eﬀects of the Ras/Raf/
MEK/ERK pathway were activated via LIF/JAK/STAT path-
way [30–32]. However, in LIF/gp130-mediated cardiac hy-
pertrophy, AG490 (JAK2 inhibitor) and PD98059 (a spe-
ciﬁc MEK inhibitor) were applied to compare the signiﬁ-
cance between ERK cascade and JAK/STAT cascade, and it
was shown that LIF-induced expression of c-fos and others
was markedly suppressed by PD98059 and moderately sup-
pressed by AG490, but STAT3 activation was not suppressed
by PD98059 and ERK1/2 activation was not suppressed by
AG490 [33]. It was suggested that the two pathways are inde-
pendent of each other.
In the present study, the airway tissues of asthmatic rats
were tested for LIF-linked substance by immunohistochem-
istry. Compared with the control, there were increased ex-
pressions for LIF and NK-1R in the asthmatic rats, and sim-
ilar changes were observed for p-STAT3 and p-ERK1/2. The
main positive cell type was airway epithelial cell, and other
types were also observed such as lymphocyte and struc-
tural cells. These results were similar to the data provided by
Knight et al [24]a n dB a ie ta l[ 34]. Combining these ﬁnd-
ings with the data mentioned above, it is hypothesized that
LIF enhances the NK-1R expression in airway of asthmatic
models, and the enhancement may be connected with the
JAK-STAT pathway or the MAPK pathway. Furthermore, air-
way epithelial cells may be the main eﬀective cell type in this
process.
To test the hypothesis, we cultured NHBE cells treated
with LIF, inhibitors of the JAK/STAT and MAPK/ERK path-
ways (AG490 and PD98059), and the activator of protein
kinase C(PMA). This study demonstrated that LIF induced
expression of NK-1R in NHBE cells, which was determined
by RT-PCR and immunocytochemistry. In this process, sim-
ilar to NK-1R, the expressions of p-STAT3 and p-ERK1/2
in NHBE cells treated with LIF all increased. Expressions
of total-STAT3 and total-ERK1/2 between LIF-treated cells
and the control cells were not signiﬁcantly diﬀerent. AG490
and PD98059 suppressed the LIF-induced expression of NK-
1R. AG490 inhibited the LIF-induced phosphorylation of
STAT3, whereas PD98059 showed no inhibition; on the con-
trary, PD98059 clearly inhibited the LIF-induced phospho-
rylation of ERK1/2, whereas AG490 showed no inhibition.
PMA, a potent activator of protein kinase C, is considered
to have a strong eﬀect to activate ERK1/2, and further in-
crease the levels of related substances in the downsteam of
ERK pathway (eg, c-fos and c-jun) [35]. Our study showed
that, compared with the control, PMA increased the expres-
sions of p-ERK1/2 and NK-1R in NHBE cells; but there was
no signiﬁcant diﬀerence between the cells stimulated with
LIF in the presence of PMA and the cells stimulated with LIF.
These ﬁndings indicated that the JAK/STAT pathway and the
MAPK pathway play diﬀerent roles in LIF-induced expres-
sion of NK-1R in NHBE cells, and suggest that these path-
ways may be independent in producing a marked biological
eﬀect.
To further conﬁrm the results mentioned above, we de-
signed this study to block STAT3 expression by siRNA. It
was found that the siRNA against STAT3 speciﬁcally reduced
STAT3 expression in LIF-induced NHBE cells. For the block-
ade of STAT3, the LIF-induced expression of NK-1R also de-
creased, whereas the expression of ERK1/2 (p-ERK1/2 and
total-ERK1/2) did not change in this process.
Inconclusion,wehavedemonstratedthatNK-1Rexpres-
sion is upregulated in NHBE cells when exposed to LIF, and
this process may be mediated by JAK2/STAT3 pathway and
ERK1/2 pathway, but no observable interaction was found
between the two pathways in the present study. Since signal-
ing cascades often converge from multiple upstream media-
tors, it is possible that the cross-talk and alternative pathways
exist. Thus, whether these factors inﬂuenced our results fur-
ther investigation is required.
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